
New medicine reduces triglyceride by 25%, no change in CVD risk in people with type 2 diabetes
A new medication, pemafibrate, lowered triglyceride levels among adults with type 2 diabetes yet did not decrease their cardiovascular risk, according to late-breaking science research presented today at the American Heart ...
Nov 7, 2022
0
18